PortfoliosLab logoPortfoliosLab logo
TALK vs. LTRN
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

TALK vs. LTRN - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Talkspace, Inc. (TALK) and Lantern Pharma Inc. (LTRN). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, TALK achieves a 43.25% return, which is significantly higher than LTRN's 26.40% return.


TALK

1D
-0.19%
1M
0.00%
YTD
43.25%
6M
41.69%
1Y
88.41%
3Y*
62.14%
5Y*
-10.39%
10Y*

LTRN

1D
-1.29%
1M
9.43%
YTD
26.40%
6M
9.43%
1Y
24.76%
3Y*
-9.22%
5Y*
-23.76%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

TALK vs. LTRN - Yearly Performance Comparison


2026 (YTD)202520242023202220212020
TALK
Talkspace, Inc.
43.25%17.48%21.65%316.19%-69.02%-81.78%8.10%
LTRN
Lantern Pharma Inc.
26.40%-5.02%-25.47%-29.14%-24.31%-58.55%55.49%

Correlation

The correlation between TALK and LTRN is 0.11, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.11

Correlation (3Y)
Calculated over the trailing 3-year period

0.18

Correlation (5Y)
Calculated over the trailing 5-year period

0.18

Correlation (All Time)
Calculated using the full available price history since Jul 30, 2020

0.16

Fundamentals

Market Cap

TALK:

$903.52M

LTRN:

$43.10M

EPS

TALK:

$0.01

LTRN:

-$1.45

PB Ratio

TALK:

7.99

LTRN:

12.51

Total Revenue (TTM)

TALK:

$238.37M

LTRN:

$0.00

Gross Profit (TTM)

TALK:

$100.68M

LTRN:

$0.00

EBITDA (TTM)

TALK:

$6.16M

LTRN:

-$16.42M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

TALK vs. LTRN — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TALK
TALK Risk / Return Rank: 8989
Overall Rank
TALK Sharpe Ratio Rank: 8888
Sharpe Ratio Rank
TALK Sortino Ratio Rank: 8888
Sortino Ratio Rank
TALK Omega Ratio Rank: 8888
Omega Ratio Rank
TALK Calmar Ratio Rank: 9090
Calmar Ratio Rank
TALK Martin Ratio Rank: 9292
Martin Ratio Rank

LTRN
LTRN Risk / Return Rank: 5454
Overall Rank
LTRN Sharpe Ratio Rank: 5252
Sharpe Ratio Rank
LTRN Sortino Ratio Rank: 5858
Sortino Ratio Rank
LTRN Omega Ratio Rank: 5959
Omega Ratio Rank
LTRN Calmar Ratio Rank: 5050
Calmar Ratio Rank
LTRN Martin Ratio Rank: 5151
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

TALK vs. LTRN - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Talkspace, Inc. (TALK) and Lantern Pharma Inc. (LTRN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


TALKLTRNDifference
Sharpe ratioReturn per unit of total volatility

+1.69

Sortino ratioReturn per unit of downside risk

+1.82

Omega ratioGain probability vs. loss probability

1.39

1.15

+0.24

Calmar ratioReturn relative to maximum drawdown

4.25

0.32

+3.94

Martin ratioReturn relative to average drawdown

13.38

0.66

+12.72

TALK vs. LTRN - Sharpe Ratio Comparison

The current TALK Sharpe Ratio is 1.95, which is higher than the LTRN Sharpe Ratio of 0.25. The chart below compares the historical Sharpe Ratios of TALK and LTRN, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

TALK vs. LTRN - Drawdown Comparison

The maximum TALK drawdown since its inception was -95.17%, roughly equal to the maximum LTRN drawdown of -94.89%. Use the drawdown chart below to compare losses from any high point for TALK and LTRN.


Loading charts...

Drawdown Indicators


TALKLTRNDifference

Max Drawdown

Largest peak-to-trough decline

-95.17%

-94.89%

-0.28%

Max Drawdown (1Y)

Largest decline over 1 year

-20.91%

-78.95%

+58.04%

Max Drawdown (3Y)

Largest decline over 3 years

-56.35%

-89.48%

+33.13%

Max Drawdown (5Y)

Largest decline over 5 years

-93.41%

-92.66%

-0.75%

Current Drawdown

Current decline from peak

-57.02%

-82.53%

+25.51%

Average Drawdown

Average peak-to-trough decline

-68.42%

-66.30%

-2.12%

Ulcer Index

Depth and duration of drawdowns from previous peaks

6.63%

37.61%

-30.98%

Volatility

TALK vs. LTRN - Volatility Comparison

The current volatility for Talkspace, Inc. (TALK) is 0.94%, while Lantern Pharma Inc. (LTRN) has a volatility of 22.23%. This indicates that TALK experiences smaller price fluctuations and is considered to be less risky than LTRN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


TALKLTRNDifference

Volatility (1M)

Calculated over the trailing 1-month period

0.94%

22.23%

-21.29%

Volatility (6M)

Calculated over the trailing 6-month period

29.75%

90.44%

-60.69%

Volatility (1Y)

Calculated over the trailing 1-year period

45.74%

97.86%

-52.12%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

68.95%

85.60%

-16.65%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

64.64%

85.10%

-20.46%

Dividends

TALK vs. LTRN - Dividend Comparison

Neither TALK nor LTRN has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

TALK vs. LTRN - Financials Comparison

This section allows you to compare key financial metrics between Talkspace, Inc. and Lantern Pharma Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0010.00M20.00M30.00M40.00M50.00M60.00M20222023202420252026
61.68M
0
(TALK) Total Revenue
(LTRN) Total Revenue
Values in USD except per share items

Frequently Asked Questions


TALK and LTRN have a correlation of 0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

LTRN has higher volatility (22.23%) compared to TALK (0.94%). In terms of maximum drawdown, TALK dropped -95.17% vs LTRN's -94.89%.

TALK currently has the higher Sharpe Ratio (1.95 vs 0.25), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for TALK and LTRN

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer